Ongoing research into Semaglutide are demonstrating significant results regarding fat reduction. Initially developed for treating diabetes , this GLP-1 receptor agonist has shown substantial efficacy https://wholesalepeptides.uk/retatrutide-vs-tirzepatide-the-next-evolution-in-metabolic-enhancement/